FI902333A0 - Menetelmä oksoftalatsinyylietikkahapon ja sen analogien valmistamiseksi - Google Patents

Menetelmä oksoftalatsinyylietikkahapon ja sen analogien valmistamiseksi

Info

Publication number
FI902333A0
FI902333A0 FI902333A FI902333A FI902333A0 FI 902333 A0 FI902333 A0 FI 902333A0 FI 902333 A FI902333 A FI 902333A FI 902333 A FI902333 A FI 902333A FI 902333 A0 FI902333 A0 FI 902333A0
Authority
FI
Finland
Prior art keywords
analogues
preparation
oxophthalazinylacetic
acid
oxophthalazinylacetic acid
Prior art date
Application number
FI902333A
Other languages
English (en)
Swedish (sv)
Other versions
FI93959B (fi
FI93959C (fi
Inventor
Banavara Lakshmana Mylari
William James Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI902333A0 publication Critical patent/FI902333A0/fi
Publication of FI93959B publication Critical patent/FI93959B/fi
Application granted granted Critical
Publication of FI93959C publication Critical patent/FI93959C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI902333A 1989-05-11 1990-05-10 Menetelmä oksoftalatsinyylietikkahapon ja sen analogien valmistamiseksi FI93959C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35099789 1989-05-11
US07/350,997 US4954629A (en) 1989-05-11 1989-05-11 Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof

Publications (3)

Publication Number Publication Date
FI902333A0 true FI902333A0 (fi) 1990-05-10
FI93959B FI93959B (fi) 1995-03-15
FI93959C FI93959C (fi) 1995-06-26

Family

ID=23379152

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902333A FI93959C (fi) 1989-05-11 1990-05-10 Menetelmä oksoftalatsinyylietikkahapon ja sen analogien valmistamiseksi

Country Status (30)

Country Link
US (1) US4954629A (fi)
EP (1) EP0397350B1 (fi)
JP (1) JPH035479A (fi)
KR (1) KR920006419B1 (fi)
CN (1) CN1025855C (fi)
AR (1) AR246968A1 (fi)
AT (1) ATE103913T1 (fi)
AU (2) AU618898B2 (fi)
BG (1) BG50609A3 (fi)
CA (1) CA2016504C (fi)
CZ (1) CZ281213B6 (fi)
DD (1) DD294257A5 (fi)
DE (1) DE69007846T2 (fi)
DK (1) DK0397350T3 (fi)
EG (1) EG19082A (fi)
ES (1) ES2063265T3 (fi)
FI (1) FI93959C (fi)
HU (1) HU212304B (fi)
IE (1) IE62591B1 (fi)
IL (3) IL94301A (fi)
MX (2) MX167455B (fi)
NO (1) NO177708C (fi)
NZ (1) NZ233597A (fi)
PH (1) PH26567A (fi)
PL (1) PL164427B1 (fi)
PT (1) PT93985B (fi)
RO (1) RO107256B1 (fi)
RU (1) RU2014333C1 (fi)
YU (1) YU91290A (fi)
ZA (1) ZA903565B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996204A (en) * 1989-05-11 1991-02-26 Pfizer Inc. Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
EP0982306A3 (en) * 1998-08-21 2000-07-05 Pfizer Products Inc. Polymorph of zopolrestat monohydrate
EP2593456B1 (en) 2010-07-16 2016-11-30 The Trustees of Columbia University in the City of New York Aldose reductase inhibitors and uses thereof
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
CN102558184B (zh) * 2011-12-30 2014-07-16 西南大学 酞嗪类衍生物的合成方法
CN102702108A (zh) * 2012-06-27 2012-10-03 上海大学 1,2-二氢酞嗪类化合物及其合成方法
CN102863393A (zh) * 2012-09-26 2013-01-09 上海大学 1,2-二氢酞嗪类化合物及其合成方法
EP3352754B1 (en) 2016-06-21 2020-09-02 The Trustees of Columbia University in the City of New York Aldose reductase inhibitors and methods of use thereof
AU2018307964B2 (en) 2017-07-28 2023-11-16 Applied Therapeutics Inc. Compositions and methods for treating galactosemia
WO2020205846A1 (en) 2019-04-01 2020-10-08 Applied Therapeutics Inc. Inhibitors of aldose reductase

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
DE3337859A1 (de) * 1983-01-21 1984-07-26 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von benzthiazolen
CA1299178C (en) * 1985-11-07 1992-04-21 Banavara Lakshmana Mylari Heterocyclic oxophtalazinyl acetic acids
ES2032749T3 (es) * 1985-11-07 1993-03-01 Pfizer Inc. Acidos oxoftalazinil-aceticos heterociclicos.
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids
WO1989006651A1 (en) * 1988-01-19 1989-07-27 Pfizer Inc. 1h-indazole-3-acetic acids as aldose reductase inhibitors
US4996204A (en) * 1989-05-11 1991-02-26 Pfizer Inc. Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors

Also Published As

Publication number Publication date
FI93959B (fi) 1995-03-15
CA2016504A1 (en) 1990-11-11
EG19082A (en) 1994-07-30
YU91290A (sh) 1992-09-07
US4954629A (en) 1990-09-04
KR920006419B1 (ko) 1992-08-06
CN1047499A (zh) 1990-12-05
CZ281213B6 (cs) 1996-07-17
PL164427B1 (pl) 1994-07-29
CN1025855C (zh) 1994-09-07
JPH0573753B2 (fi) 1993-10-15
DE69007846T2 (de) 1994-07-28
AU8680691A (en) 1992-01-02
CA2016504C (en) 1999-07-27
JPH035479A (ja) 1991-01-11
MX9207687A (es) 1994-06-30
PT93985A (pt) 1991-01-08
EP0397350B1 (en) 1994-04-06
HU212304B (en) 1996-05-28
BG50609A3 (en) 1992-09-15
DK0397350T3 (da) 1994-05-09
AU626225B2 (en) 1992-07-23
RU2014333C1 (ru) 1994-06-15
DD294257A5 (de) 1991-09-26
IL94301A (en) 1996-01-19
PH26567A (en) 1992-08-19
PT93985B (pt) 1996-11-29
NO902071D0 (no) 1990-05-10
AR246968A1 (es) 1994-10-31
ATE103913T1 (de) 1994-04-15
FI93959C (fi) 1995-06-26
RO107256B1 (ro) 1993-10-30
IL114271A0 (en) 1995-10-31
EP0397350A1 (en) 1990-11-14
AU618898B2 (en) 1992-01-09
KR900018114A (ko) 1990-12-20
AU5490690A (en) 1990-11-15
IE901626L (en) 1990-11-11
CZ227890A3 (en) 1996-04-17
NO177708C (no) 1995-11-08
MX167455B (es) 1993-03-23
NO177708B (no) 1995-07-31
IE62591B1 (en) 1995-02-08
HU902995D0 (en) 1990-09-28
NZ233597A (en) 1992-02-25
DE69007846D1 (de) 1994-05-11
ZA903565B (en) 1991-12-24
NO902071L (no) 1990-11-12
ES2063265T3 (es) 1995-01-01
PL285113A1 (en) 1991-07-15
IL114271A (en) 1998-04-05
HUT54690A (en) 1991-03-28
IL94301A0 (en) 1991-03-10

Similar Documents

Publication Publication Date Title
PT87754A (pt) Process for the preparation of new amino acid derivatives
DE69031814T2 (de) Verfahren zur Herstellung von Polyoxyalkylenderivaten
BR8706496A (pt) Processo para preparacao de compostos e utilizacao
PT90637A (pt) Processo de preparacao de polianidridos
PT84790B (pt) Processo de preparacao de derivados de amino-tiazol e de amino-oxazole e de composicoes farmaceuticas contendo-os
FI891074A0 (fi) Menetelmä syklisten sulfaattien valmistamiseksi
BR8905349A (pt) Processo para a preparacao de uma cicloalcanona e/ou um cicloalcanol
PT87153A (pt) Process for the preparation of acid ribofuranuronic derivatives
FI935791A (fi) Menetelmä polyhydroksikarboksyylihapon valmistamiseksi
DE69027569D1 (de) Verfahren zur Herstellung von Enynderivaten
FI902333A0 (fi) Menetelmä oksoftalatsinyylietikkahapon ja sen analogien valmistamiseksi
FI91961C (fi) Menetelmä (S)- -etyyli-2-okso-1-pyrrolidiiniasetamidin valmistamiseksi
FI885692A0 (fi) Karboksimetyylisulfoetyyliselluloosa ja menetelmä sen valmistamiseksi
FI880301A (fi) Aminomuovihartsi ja menetelmä sen valmistamiseksi
BR8807384A (pt) Processo para a preparacao de anidridos oxi-diftalicos
IT8947842A0 (it) Procedimento per la produzione di r(+) amminocarnitina e s(-) amminocarnitina
IL79964A0 (en) Process for the preparation of optically active alpha-phenoxy-propionic acid and its derivatives
ZA891534B (en) Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof
FI890477A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 2,5-diamino-6-fluoriheksaanihapon ja sen suolojen valmistamiseksi
PT86776A (pt) Process for the preparation of piperazinecarboxylic acid and pharmaceutical compositions containing it
PT89578A (pt) Processo de preparacao de acido n-fosfono-metil-imino-diacetico
PT84184A (pt) Process for the preparation of 8 alpha-acylaminoergolines and of pharmaceutical compositions containing them
IT8919339A0 (it) Procedimento per la preparazione di acido n fosfonometiliminodiacetico e di cloruri di acidi.
BR8905815A (pt) Processo para preparacao de cetoximossilanos
IT8621734A0 (it) Processo per la preparazione dell'alfa-n-[(ipoxatin-9-il)pentilossicarbonil-]arginina

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: PFIZER INC.